Citius Oncology, Inc.

CTOR ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Oct 23, 2026 CURRENT REPORT
8-K Sep 29, 2026 CURRENT REPORT
ARS Aug 26, 2026 FORM ARS
DEF 14A Aug 26, 2026 DEFINITIVE PROXY STATEMENT
3 Aug 14, 2026 PRIMARY DOCUMENT
424B3 Aug 14, 2026 PROSPECTUS
10-Q Aug 14, 2026 QUARTERLY REPORT
8-K Aug 14, 2026 CURRENT REPORT
SCHEDULE 13G/A Aug 14, 2026
8-K Aug 12, 2026 CURRENT REPORT
424B3 Aug 5, 2026 PROSPECTUS SUPPLEMENT
8-K Aug 5, 2026 CURRENT REPORT
EFFECT Jun 5, 2026
SCHEDULE 13D/A Jun 4, 2026
CORRESP Jun 3, 2026
UPLOAD Jun 3, 2026
424B3 Jun 1, 2026 424B3
8-K Jun 1, 2026 CURRENT REPORT
DEF 14C May 29, 2026 DEFINITIVE INFORMATION STATEMENT
S-3 May 29, 2026 REGISTRATION STATEMENT
424B3 May 22, 2026 PROSPECTUS SUPPLEMENT
PRE 14C May 19, 2026 PRELIMINARY INFORMATION STATEMENT
8-K May 15, 2026 CURRENT REPORT
10-Q May 15, 2026 QUARTERLY REPORT
SCHEDULE 13G/A May 15, 2026
← Newer Page 1 of 11 · 266 filings Older →